eversyn is a spin-off of the Max Planck Institute Magdeburg - run, founded and supported by current and former Max Planck scientists and business professionals. Our proprietary technology is based on the efficient use of novel, GMO-free biocatalytic cascades. We have designed and engineered these pathways to produce nucleotide sugars by magnitude of orders cheaper than the current production costs. Building on that, we are engineering biocatalysts to produce human milk oligosaccharides and tailor the glycosylation of therapeutic proteins.